Regen BioPharma© COPYRIGHT 2017. ALL RIGHTS RESERVED.
|
Company Overview
• Founded in 2012 as a biotechnology company focused on stem cell and immunotherapies for specialty niche treatments.
• Fully reporting and trades publicly under the symbol: RGBP • Focused on immuno-oncology, stem cell/cancer stem cell, gene silencing • Currently 2 Investigational New Drug applications (IND) filed with the FDA • Three products in preclinical development based on the newly discovered cancer stem cell gene target |
